Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Pharmacy Practice|January 17, 2022
Key Points for Pharmacists From the ACC Expert Consensus Decision Pathway for Patients Hospitalized With Heart FailureKatie B Tellor, Anastasia L Armbruster
The Annals of Pharmacotherapy|April 10, 2015
Edoxaban, a Novel Oral Factor Xa InhibitorChelsea Minor, Katie B Tellor, Anastasia L Armbruster
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
Extended-Duration Venous Thromboembolism Prophylaxis in Hospitalized Acutely Ill Medical Patients: A Review of the EvidenceKatie B Tellor, Anastasia L Armbruster, James M Hollands
Pharmacotherapy|January 25, 2017
Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal ImpairmentBrooke E Stanton, Naomi S Barasch, Katie B Tellor
Therapeutics and Clinical Risk Management|May 25, 2016
Comparative risk impact of edoxaban in the management of stroke and venous thromboembolismKatie B Tellor, Joseph S Van Tuyl, Anastasia L Armbruster
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
Evaluation of Apixaban for the Treatment of Nonvalvular Atrial Fibrillation With Regard to Dosing and Safety in a Community HospitalKatie B Tellor, Michelle Wang, Melissa S Green, et al.
Journal of Clinical Pharmacy and Therapeutics|May 7, 2019
Evaluation of the effect of prior antiarrhythmic drug use on the success of atrial fibrillation catheter ablationMichelle Wang, Katie B Tellor, Karthik Ramaswamy, et al.
Journal of Community Hospital Internal Medicine Perspectives|March 5, 2020
Evaluating the safety and tolerability of inpatient sacubitril/valsartan initiation in a community hospitalKatie L Peppin, Katie B Tellor, Anastasia L Armbruster, et al.
Pageof 2